Drawing for SAOR

USPTO serial 99432756

SAOR

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
DEAN, JULES J.
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with SAOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,844*

Plus Government fees of $900

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David S. Miller

David S. Miller McDonnell Boehnen Hulbert & Berghoff LLP300 South Wacker DriveSuite 3100Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
009Computer software relating to the medical field, namely, downloadable computer software for tracking user's glucose level and time and dose of drug injection of user of an autoinjector; Software as a medical device (SaMD), downloadable, for measuring glucose level and amount of drug injected by user of an autoinjectorACTIVE—
010Medical apparatus and instruments, namely, drug injection dose and time measuring apparatus for administering drugs; Medical test kits for diabetes monitoring for home use; Medical instruments for therapeutic drug monitoring; Patient monitoring instruments, namely, medical instruments for monitoring patient glucose level, and drug injection time and dose; Monitoring instruments, namely, monitoring devices for monitoring of user's glucose levels and drug injection time and dose for medical purposes; Monitoring apparatus and instruments, namely, monitoring devices for monitoring of user's glucose levels and drug injection time and dose for medical purposes; Measuring instruments, namely, measuring devices for measuring glucose level and amount of drug injected by user of an autoinjector; Measuring devices, namely, measuring devices for measuring glucose level and amount of drug injected by user of an autoinjectorACTIVE—
035Data processing services; Automated data processing services; Computerised data processing services; Computer data entry services and data processing services; Data processing services in the field of healthcare; Maintaining personal medical history records and files; Maintaining files and records concerning the medical condition of individuals; Electronic data processing services; Data processing for businesses and management; Data processing services, namely, automated processing of medical dataACTIVE—
038Communications by cellular phones; Communication by computer terminals; Wireless broadcasting; Providing access to databases; Transmission of digital files; Computer aided transmission of messages and images; Streaming of data; Transmission of electronic mail; Video-on-demand transmissionACTIVE—
042Cloud computing featuring software for tracking drug injection time and dose, and user's glucose level; engineering services; Software as a service (SAAS) services featuring software for tracking drug injection time and dose, and user's glucose level; electronic data storage; platform as a service (PaaS) services featuring software for tracking drug injection time and dose, and user's glucose levelACTIVE—
044Dietary and nutritional guidance and advice; health assessment services; health counselling; medical assistance; pharmacy advice, namely, pharmaceutical advice; preparation of prescriptions by pharmacists; remote monitoring of medical data for medical diagnosis and treatment; telemedicine services; Diabetes screening services; Medical services in the field of diabetes; Providing information via the Internet in the field of diabetes; Medical services, namely, issuing of medical reports; Medical services, namely, compilation of medical reports; Medical advisory services, namely, advisory services relating to medical apparatus and instruments; Medical analysis services relating to the treatment of patients; Medical services, namely, monitoring of patients; Medical services, namely, providing medical support in the monitoring of patients receiving medical treatments; Providing information relating to the preparation and dispensing of medications; Advisory services relating to health; Advisory services relating to pharmacies, namely, pharmaceutical advice; Advisory services relating to health care; Medical advisory services, namely, advisory services relating to medical problems; Advisory services relating to medical services; Health advice and information services; Health care consultancy services; Health risk assessment, namely, providing medical information, consultancy and advisory services; Healthcare advisory services; Providing healthcare information; Individual medical counseling services provided to patients; Medical information, namely, information relating to health; Providing information relating to nutrition; Information services relating to health care, namely, providing healthcare information; Medical advisory services; Medical analysis services relating to the treatment of persons; Medical and healthcare services; Medical assistance consultancy provided by doctors and other specialized medical personnel; Medical assistance services; Medical care services; Medical consultancy services; Medical consultation; Medical examination of individuals and provision of reports related thereto; Medical examination services; Medical health assessment services; Medical information; Provision of medical information; Medical information services; Medical information services provided via the Internet; Medical services for the treatment of conditions of the human body; Medical tele-reporting, namely, provision of medical services by health care professionals via the internet or telecommunication networks; Medical treatment services, namely, medical treatment of diabetes, migraines, infertility, growth problems and obesity; Medication counseling; Medical information, namely, preparation of reports relating to health care matters; Medical information, namely, preparation of reports relating to medical matters; Professional consultancy relating to health care; Professional consultancy relating to health; Providing health care information by telephone; Providing health care information via a global computer network; Providing health information; Providing information relating to medical services; Providing information to patients in the field of administering medications; Providing medical information; Providing nutritional information about food; Medical information, namely, providing online medical record services other than dentistry; Provision of health care services; Provision of health information; Provision of information relating to medicine; Medical information, namely, services for the preparation of medical reports; Medical tele-reporting services, namely, provision of medical services by health care professionals via the internet or telecommunication networksACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Jul 14, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 19, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 19, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 13, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 13, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 23, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 16, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 16, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 16, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 27, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 26, 2026DOCKASSIGNED TO EXAMINER—
Feb 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 8, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 8, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance